Cargando…

The association between premorbid beta blocker exposure and mortality in sepsis—a systematic review

BACKGROUND: The effect of premorbid β-blocker exposure on clinical outcomes in patients with sepsis is not well characterized. We aimed to examine the association between premorbid β-blocker exposure and mortality in sepsis. METHODS: EMBase, MEDLINE, and Cochrane databases were searched for all stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Kaiquan, Harazim, Martin, Tang, Benjamin, Mclean, Anthony, Nalos, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727531/ https://www.ncbi.nlm.nih.gov/pubmed/31484576 http://dx.doi.org/10.1186/s13054-019-2562-y

Ejemplares similares

Correction to: The association between premorbid beta blocker exposure and mortality in sepsis—a systematic review
por: Tan, Kaiquan, et al.
Publicado: (2020)

The Association of Premorbid Metformin Exposure With Mortality and Organ Dysfunction in Sepsis: A Systematic Review and Meta-Analysis
por: Tan, Kaiquan, et al.
Publicado: (2019)

Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies
por: Hong, Shiao-Ya, et al.
Publicado: (2023)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis
por: Huang, Stephen J, et al.
Publicado: (2013)

Accuracy of Quick Sequential Organ Failure Assessment Score to Predict Sepsis Mortality in 121 Studies Including 1,716,017 Individuals: A Systematic Review and Meta-Analysis
por: Herwanto, Velma, et al.
Publicado: (2019)

Premorbid β1-selective (but not non-selective) β-blocker exposure reduces intensive care unit mortality among septic patients
por: Kuo, Ming-Jen, et al.
Publicado: (2021)

Blood transcriptome analysis of patients with uncomplicated bacterial infection and sepsis
por: Herwanto, Velma, et al.
Publicado: (2021)

Understanding Hyperlactatemia in Sepsis: Are We There Yet?
por: Nalos, Marek, et al.
Publicado: (2019)

90-day mortality of severe sepsis and septic shock is reduced by initiation of oral beta-blocker therapy and increased by discontinuation of a pre-existing beta-blocker treatment
por: Fuchs, C, et al.
Publicado: (2015)

Premorbid beta blockade in sepsis is associated with a lower risk of a lactate concentration above the lactate threshold, a retrospective cohort study
por: Schneider, Liam, et al.
Publicado: (2022)

Early premorbid of children with ASD
por: Kalinina, M., et al.
Publicado: (2021)

Beta-blocker use and COPD mortality: a systematic review and meta-analysis
por: Etminan, Mahyar, et al.
Publicado: (2012)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

Systematic review of use of β-blockers in sepsis
por: Chacko, Cyril Jacob, et al.
Publicado: (2015)

Phenotypical analysis of peripheral human T lymphocytes in early sepsis
por: Nalos, M, et al.
Publicado: (2010)

Premorbid weight in pulmonary arterial hypertension
por: Oppegard, Laura J., et al.
Publicado: (2023)

Aberrant Cell Cycle and Apoptotic Changes Characterise Severe Influenza A Infection – A Meta-Analysis of Genomic Signatures in Circulating Leukocytes
por: Parnell, Grant, et al.
Publicado: (2011)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Higher premorbid serum testosterone predicts COVID-19-related mortality risk in men
por: Yeap, Bu B, et al.
Publicado: (2022)

Transcriptional reprogramming of metabolic pathways in critically ill patients
por: Nalos, Marek, et al.
Publicado: (2016)

New potential for an old kid on the block: Impact of premorbid metformin use on lactate kinetics, kidney injury and mortality in sepsis and septic shock, an observational study
por: Van Moorter, Nina, et al.
Publicado: (2022)

Correlation between premorbid IL-6 levels and COVID-19 mortality: Potential role for Vitamin D
por: Silberstein, Morry
Publicado: (2020)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Exploring the Impact of Prior Beta-Blocker and Calcium Channel Blocker Usage on Clinical Outcomes in Critically Ill Patients With Sepsis: An Observational Study
por: Kumar, Sachin, et al.
Publicado: (2023)

Beta-Blocker Therapy Preserves Normal Splenic T-Lymphocyte Numbers Reduced in Proportion to Sepsis Severity in a Sepsis Model
por: Suzuki, Takeshi, et al.
Publicado: (2019)

Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study
por: Pinnock, Claude, et al.
Publicado: (2016)

Pharmacological differences between beta-blockers and postoperative mortality following colon cancer surgery
por: Ekestubbe, Lovisa, et al.
Publicado: (2022)

β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)

Premorbid Clinical Frailty Score and 30‐day mortality among older adults in the emergency department
por: Huh, Ji Young, et al.
Publicado: (2022)

Associations of Multimorbidity With Stroke Severity, Subtype, Premorbid Disability, and Early Mortality: Oxford Vascular Study
por: Downer, Matthew B., et al.
Publicado: (2023)

Beta-blockers in septic shock: What is new?
por: Lescroart, Mickael, et al.
Publicado: (2022)

Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
por: de Roquetaillade, Charles, et al.
Publicado: (2022)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

New Insights into the Interaction between Graphene Oxide and Beta-Blockers
por: Deng, Yuehua, et al.
Publicado: (2019)

D-53 | Impact of Cardiovascular Diseases, Calcium Channel Blockers and Beta-Blockers on Mortality of Patients Hospitalized with COVID-19
por: Alhusain, Rashid, et al.
Publicado: (2022)

Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients
por: Lu, Hua, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b34qg9qductm98iukrci73jbn3